期刊文献+

糖尿病足溃疡时血小板聚集、释放和膜糖蛋白Ⅵ变化的临床研究 被引量:1

Clinical research of platelet aggregation, release and change of membrane glycoprotein Ⅵ in diabetic foot ulceration
下载PDF
导出
摘要 目的研究糖尿病足溃疡患者血小板聚集、释放和膜糖蛋白Ⅵ(GPⅥ)的变化。方法 42例2型糖尿病患者按有无糖尿病足分为:非糖尿病足(DM)组(未患糖尿病足)17例和糖尿病足(DFU)组25例;同时选取15例健康志愿者为对照组。检测空腹血糖值、糖化血红蛋白、血小板聚集率、血小板P选择素释放和血小板GPⅥ阳性率。结果 DFU组空腹血糖值和糖化血红蛋白(Hb A1c)两项指标均高于对照组(P<0.05);DFU组血小板聚集率显著高于对照组与DM组(P<0.05);DFU组血小板P选择素释放高于对照组与DM组(P<0.05);DFU组的GPⅥ阳性率高于对照组和DM组,差异均具有统计学意义(P<0.05)。结论血小板功能的变化可能与糖尿病足的发病有关。 Objective To research platelet aggregation, release and change of membrane glycoprotein Ⅵ in diabetic foot ulceration. Methods A total of 42 patients with type 2 diabetes mellitus were divided into non diabetic foot(DM)group(without diabetic foot) with 17 cases and diabetic foot(DFU) group with 25 cases. Another 15 healthy volunteers were selected as control group. Detection was made on fasting blood-glucose, glycosylated hemoglobin, platelet aggregation rate, platelet P-selectin release, and platelet GP Ⅵ positive rate. Results DFU group had higher indexes of fasting blood-glucose and glycosylated hemoglobin(Hb A1c) than the control group(P〈0.05). DFU group had higher platelet aggregation rate than the control group and DM group(P〈0.05). DFU group had higher platelet P-selectin release than the control group and DM group(P〈0.05). DFU group had higher GP Ⅵ positive rate than the control group and DM group, and the differences had statistical significance(P〈0.05). Conclusion Change of platelet function have relationship with the progress of diabetic foot.
出处 《中国实用医药》 2015年第7期28-29,共2页 China Practical Medicine
基金 江苏省镇江市科技支撑计划指导性项目(项目编号:F22012040)
关键词 糖尿病足 溃疡 血小板 聚集率 膜糖蛋白Ⅵ P选择素 Diabetic foot Ulceration Platelet aggregation rate Membrane glycoprotein Ⅵ P-selectin
  • 相关文献

参考文献15

  • 1Dixon JB, le Roux CW, Rubino F, et al. Bariatric surgery for type 2 diabetes. Lancet, 2012, 379(9833):2300-2311,.
  • 2Hobizal KB, Wukich DK. Diabetic foot infections: current concept review. Diabet Foot Ankle, 2012:3. doi: 10.3402/dfa.v3iO. 18409.
  • 3Alexiadou K, Doupis J. Management of diabetic foot ulcers. Diabetes Ther, 2012, 3(1):4.
  • 4Korkmaz M, Erdogan Y, Balci M, et al. Preoperative medical treatment in patients undergoing diabetic foot surgery with a Wagner Grade-3 or higher ulcer: a retrospective analysis of 52 patients. Diahet Foot Ankle, 2012:3. doi: lO.3402/dfa.v3i0.18838.
  • 5Liu D, Liang F, Wang X, et al. Suppressive effect of CORM-2 on LPS-induced platelet activation by glycoprotein mediated HS1 phosphorylation interference. PLoS One, 2013, 8(12):e83112.
  • 6Tabak AG, Herder C, Rathmann W, et al. Prediabetes: a high-risk state for diabetes development. Lancet, 2012, 379(9833):2279- 2290.
  • 7冯雪琴,张汉奎,兰海丽,卢兰芬,吴秀娟,何顺宁.糖尿病足部溃疡感染情况及其影响因素分析[J].检验医学与临床,2010,7(14):1423-1425. 被引量:11
  • 8Bowering CK. Diabetic foot ulcers, Pathophysiology, assessment, and therapy. Can Faro Physician, 2001(47):1007-1016.
  • 9Dinh T, Tecilazich F, Kafanas A, et al. Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes, 2012, 61(11):2937-2947.
  • 10Gieger C, Radhakrishnan A, Cvcjic A, et al. New gene functions in megakaryopoiesis and platelet formation. Nature, 2011,480(7376): 201-208.

二级参考文献8

共引文献10

同被引文献11

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部